We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+48.85%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$634M
AUM Growth
+$33.5M
(+5.6%)
Cap. Flow
-$90.2M
Cap. Flow
% of AUM
-14.22%
Top 10 Holdings %
Top 10 Hldgs %
8.15%
Holding
413
New
130
Increased
19
Reduced
118
Closed
127
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LivePerson
LPSN
|
+$4.19M |
| 2 |
NVTR
Nuvectra Corporation Common Stock
NVTR
|
+$4.14M |
| 3 |
TBCH
Turtle Beach Corp
TBCH
|
+$4.13M |
| 4 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$4.07M |
| 5 |
Tactile Systems Technology
TCMD
|
+$4.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$6.81M |
| 2 |
CUTR
Cutera, Inc.
CUTR
|
+$4.92M |
| 3 |
Vericel Corp
VCEL
|
+$4.77M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$4.75M |
| 5 |
INST
Instructure, Inc.
INST
|
+$4.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.66% |
| 2 | Technology | 24.9% |
| 3 | Consumer Discretionary | 14.4% |
| 4 | Industrials | 10.81% |
| 5 | Financials | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vicor
VICR
$9.42B
| $3.45M | 0.54% |
+79,197
| New | +$3.06M |
|
52
Novanta
NOVT
$4.95B
| $3.44M | 0.54% |
55,270
-5,730
| -9% | -$350K |
|
|
POLY
53
DELISTED
Plantronics, Inc.
POLY
| $3.43M | 0.54% |
+45,024
| New | +$3.11M |
|
54
Haemonetics
HAE
$3.85B
| $3.43M | 0.54% |
38,228
-3,851
| -9% | -$325K |
|
55
Sarepta Therapeutics
SRPT
$1.64B
| $3.4M | 0.54% |
25,692
-14,288
| -36% | -$1.35M |
|
|
NXGN
56
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $3.39M | 0.53% |
+173,659
| New | +$2.74M |
|
57
Churchill Downs
CHDN
$5.76B
| $3.37M | 0.53% |
+68,232
| New | +$3.19M |
|
58
Trex
TREX
$4.56B
| $3.37M | 0.53% |
+107,634
| New | +$3.12M |
|
59
AeroVironment
AVAV
$7.42B
| $3.37M | 0.53% |
+47,144
| New | +$2.68M |
|
60
nLIGHT
LASR
$3.71B
| $3.36M | 0.53% |
+101,757
| New | +$3.42M |
|
|
FRGI
61
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $3.36M | 0.53% |
+117,151
| New | +$2.73M |
|
|
DCPH
62
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $3.35M | 0.53% |
+85,026
| New | +$2.5M |
|
63
RingCentral
RNG
$4.48B
| $3.33M | 0.53% |
47,411
-4,782
| -9% | -$342K |
|
|
CRAY
64
DELISTED
Cray, Inc.
CRAY
| $3.33M | 0.53% |
+135,514
| New | +$3.37M |
|
|
EPAY
65
DELISTED
Bottomline Technologies Inc
EPAY
| $3.33M | 0.53% |
+66,886
| New | +$2.98M |
|
|
KMG
66
DELISTED
KMG Chemicals Inc
KMG
| $3.33M | 0.53% |
45,169
-16,201
| -26% | -$1.09M |
|
67
ICU Medical
ICUI
$4.21B
| $3.33M | 0.53% |
11,339
-1,145
| -9% | -$313K |
|
68
The Ensign Group
ENSG
$10.4B
| $3.31M | 0.52% |
+98,825
| New | +$3.05M |
|
69
Verastem
VSTM
$536M
| $3.29M | 0.52% |
+39,822
| New | +$2.44M |
|
|
LHCG
70
DELISTED
LHC Group LLC
LHCG
| $3.27M | 0.52% |
+38,236
| New | +$2.91M |
|
71
Semtech
SMTC
$10.7B
| $3.26M | 0.51% |
+69,309
| New | +$3.11M |
|
72
CONMED
CNMD
$1.41B
| $3.25M | 0.51% |
44,357
-4,461
| -9% | -$303K |
|
73
Supernus Pharmaceuticals
SUPN
$2.65B
| $3.23M | 0.51% |
+53,910
| New | +$2.79M |
|
74
Integer Holdings
ITGR
$3.42B
| $3.22M | 0.51% |
49,854
-5,016
| -9% | -$311K |
|
75
Boot Barn
BOOT
$4.68B
| $3.22M | 0.51% |
154,989
-44,097
| -22% | -$930K |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q2 2018 Portfolio in Review
As of Q2 2018, EAM Investors held 413 positions worth $634M, up 5.6% from $601M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
EAM Investors withdrew a net $90.2M in Q2 2018, closing 127 positions and reducing 118 holdings. Its most notable exit was Nektar Therapeutics, an estimated $6.81M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, EAM Investors opened a new position in LivePerson worth $4.69M.
- EAM Investors's largest Q2 2018 buy was LivePerson: 14,807 shares worth $4.69M.
- EAM Investors added most to Malibu Boats in Q2 2018, an estimated $3.06M increase.
- EAM Investors's biggest Q2 2018 reduction was Vericel Corp, cutting an estimated $4.77M.
- EAM Investors fully exited Nektar Therapeutics in Q2 2018, selling an estimated $6.81M.
- EAM Investors's ten largest holdings make up 8.1% of its $634M portfolio in Q2 2018.
- EAM Investors opened 130 new positions and closed 127 in Q2 2018.
- EAM Investors's portfolio value rose 5.6% quarter-over-quarter to $634M.
Based on EAM Investors's 13F filing for Q2 2018, filed 3 Aug 2018.